Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt/β‐catenin pathway
Open Access
- 23 July 2007
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 121 (6), 1360-1365
- https://doi.org/10.1002/ijc.22804
Abstract
Artesunate (ART), a remarkable antimalarial agent, also inhibited the growth of human colorectal carcinoma. As determined by MTT assay, flow cytometry analysis on apoptosis and indirect immunofluorescence analysis on the proliferation-associated marker Ki67, ART suppressed the proliferation and promoted the apoptosis of colorectal cancer cells in a dose-dependent manner. Furthermore, immunofluorescence analysis on β-catenin and RT-PCR analysis on Wnt/β-catenin target genes demonstrated ART translocated β-catenin from nucleus to adherent junctions of membrane and reduced transcription mediated by β-catenin. These results suggested the anticancer activity of ART correlated with the inhibition of hyperactive Wnt/β-catenin signaling pathway. In vivo, ART significantly slowed the growth of colorectal tumor xenografts. Bioluminescent imaging also revealed that ART decreased the physiological activity of tumor xenografts and delayed spontaneous liver metastasis. These antitumor effects were related to the membranous translocation of β-catenin and the inhibition of the unrestricted activation of Wnt/β-catenin pathway, which was confirmed by the immunohistochemical staining of tumor tissues. These results and the known low toxicity are clues that ART might be a promising candidate drug for the treatment of colorectal carcinoma.This publication has 31 references indexed in Scilit:
- Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunateBiochemical Pharmacology, 2004
- Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous ironFree Radical Biology & Medicine, 2004
- Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitroPharmacological Research, 2003
- Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cellsLife Sciences, 2001
- Free radicals and reactive oxygen species in programmed cell deathMedical Hypotheses, 1999
- Pharmacokinetics of Artemisinin and Artesunate after Oral Administration in Healthy VolunteersThe American Journal of Tropical Medicine and Hygiene, 1997
- The toxicity of artemisinin and related compounds on neuronal and glial cells in cultureChemico-Biological Interactions, 1995
- QinghaosuThe Lancet, 1993
- Hemin-catalyzed decomposition of artemisinin (qinghaosu)Biochemical Pharmacology, 1992
- Qinghaosu (Artemisinin): an Antimalarial Drug from ChinaScience, 1985